Clinical Trials Browser

Phase 2 × Opsoclonus-Myoclonus Syndrome × Rituximab × Clear all

NCT00202930 2021-01-22

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

Phase 2 Terminated

4 enrolled 6 charts

Neuroblastoma, Opsoclonus-Myoclonus Syndrome